Hyperrho Solution
Product Images NDC 13533-631

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Hyperrho (NDC 13533-631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10packcarton

Rho(D) Immune Globulin (Human) called HyperRHO S/D Full Dose is a pharmaceutical product that has been treated with Solvent/Detergent. It is an injectable drug that is used as a preservative. The text also mentions a pharmacy identification code or NDC 13533-631-11.*

FDA Label Image

In-bloodstream (Bloodstream)

FDA Label Image

Carton

This is a product description for HyperRHO® S/D Full Dose, a solvent/detergent treated immune globulin used to prevent Rh sensitization in Rh-negative women who have given birth to Rh-positive babies. The product comes in a single-dose disposable syringe with attached needle and should be administered intramuscularly, preferably within three days after miscarriage or delivery of an Rh-positive infant. It should not be administered intravenously or to neonates. The patient and physician should discuss the product's risks and benefits before use. Additional dosage and administration information can be found in the enclosed package insert, as well as directions for syringe usage. The product should not be used if the syringe is prematurely engaged and is not returnable for credit or exchange. The product should be stored at 2-8°C (36-46°F) and should not be frozen.*

FDA Label Image

Digrams-a-b-c (Diagramabc)

FDA Label Image

Father-positive-mother-negative (Father Pos Mother Neg)

FDA Label Image

Id Card

HyperRHO S/D is a medication that is a solvent/detergent treated Rho(D) immune globulin made for Injection. This medication is used in pregnancy and postpartum for women who are Rh negative and Rh-positive fetal cells might mingle with maternal blood during pregnancy or delivery. The text includes information such as patient details, dosage instructions, and laboratory information. It also includes a note regarding the presence of a passive antibody following antepartum administration of HyperRHO SID. This medication should be administered to the patient to protect them during pregnancy (especially if the pregnancy is beyond 13 weeks' gestation) or to prevent the risk of disease following a miscarriage or abortion.*

FDA Label Image

Injection (Injected)

FDA Label Image

Mother-neg-baby-pos (Mother Neg Baby Pos)

FDA Label Image

Mother-negative (Mother Neg)

FDA Label Image

Next-pregnancy (Next Pregnancy)

FDA Label Image

Pregnant Woman (Pregnant)

FDA Label Image

Stay-in-bloodstream (Stay In Bloodstream)

FDA Label Image

Hyperrho Sd Full Dose Syringe (Syringe)

This appears to be a lot number (3047858) and expiration date for a medical product called "HyperRHO S/D Full Dose" which is a solvent/detergent treated Rho(D) immune globulin used in medical treatments. The product is made by Grifols Therapeutics LLC and the patient and medical professionals should discuss the benefits of using this product. No further information can be determined from the provided text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.